Remed Statistics

Total Valuation

Remed has a market cap or net worth of KRW 95.50 billion. The enterprise value is 89.89 billion.

Market Cap	95.50B
Enterprise Value	89.89B

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Remed has 30.91 million shares outstanding. The number of shares has increased by 81.79% in one year.

Current Share Class	30.91M
Shares Outstanding	30.91M
Shares Change (YoY)	+81.79%
Shares Change (QoQ)	+1.46%
Owned by Insiders (%)	36.09%
Owned by Institutions (%)	0.18%
Float	19.75M

Valuation Ratios

The trailing PE ratio is 181.50.

PE Ratio	181.50
Forward PE	n/a
PS Ratio	3.90
PB Ratio	2.27
P/TBV Ratio	2.48
P/FCF Ratio	62.44
P/OCF Ratio	39.85
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.96, with an EV/FCF ratio of 58.77.

EV / Earnings	170.83
EV / Sales	3.67
EV / EBITDA	41.96
EV / EBIT	123.84
EV / FCF	58.77

Financial Position

The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.13.

Current Ratio	4.03
Quick Ratio	2.91
Debt / Equity	0.13
Debt / EBITDA	2.54
Debt / FCF	3.55
Interest Coverage	0.83

Financial Efficiency

Return on equity (ROE) is -0.08% and return on invested capital (ROIC) is 2.19%.

Return on Equity (ROE)	-0.08%
Return on Assets (ROA)	0.80%
Return on Invested Capital (ROIC)	2.19%
Return on Capital Employed (ROCE)	1.54%
Weighted Average Cost of Capital (WACC)	8.67%
Revenue Per Employee	266.36M
Profits Per Employee	5.72M
Employee Count	92
Asset Turnover	0.43
Inventory Turnover	1.55

Taxes

Income Tax	-263.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.40% in the last 52 weeks. The beta is 0.76, so Remed's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-9.40%
50-Day Moving Average	3,133.70
200-Day Moving Average	3,220.25
Relative Strength Index (RSI)	50.20
Average Volume (20 Days)	116,764

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remed had revenue of KRW 24.50 billion and earned 526.20 million in profits. Earnings per share was 9.00.

Revenue	24.50B
Gross Profit	13.96B
Operating Income	725.84M
Pretax Income	-299.35M
Net Income	526.20M
EBITDA	2.14B
EBIT	725.84M
Earnings Per Share (EPS)	9.00

Full Income Statement

Balance Sheet

The company has 13.03 billion in cash and 5.43 billion in debt, giving a net cash position of 7.60 billion or 245.78 per share.

Cash & Cash Equivalents	13.03B
Total Debt	5.43B
Net Cash	7.60B
Net Cash Per Share	245.78
Equity (Book Value)	42.05B
Book Value Per Share	1,274.36
Working Capital	20.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.40 billion and capital expenditures -866.76 million, giving a free cash flow of 1.53 billion.

Operating Cash Flow	2.40B
Capital Expenditures	-866.76M
Depreciation & Amortization	1.42B
Net Borrowing	-2.26B
Free Cash Flow	1.53B
FCF Per Share	49.49

Full Cash Flow Statement

Margins

Gross margin is 56.98%, with operating and profit margins of 2.96% and 2.15%.

Gross Margin	56.98%
Operating Margin	2.96%
Pretax Margin	-1.22%
Profit Margin	2.15%
EBITDA Margin	8.74%
EBIT Margin	2.96%
FCF Margin	6.24%

Dividends & Yields

Remed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.79%
Shareholder Yield	-81.79%
Earnings Yield	0.55%
FCF Yield	1.60%

Stock Splits

The last stock split was on December 8, 2023. It was a forward split with a ratio of 5.

Last Split Date	Dec 8, 2023
Split Type	Forward
Split Ratio	5

Scores

Remed has an Altman Z-Score of 6.49 and a Piotroski F-Score of 6.

Altman Z-Score	6.49
Piotroski F-Score	6